| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/12/2012 | CA2804327A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof |
| 01/12/2012 | CA2804274A1 Factor ix polypeptides and methods of use thereof |
| 01/12/2012 | CA2804256A1 Bacterial surface display and screening of thioether-bridge-containing peptides |
| 01/12/2012 | CA2804214A1 Methods and compositions for the specific inhibition of beta-catenin by double-stranded rna |
| 01/12/2012 | CA2804210A1 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna |
| 01/12/2012 | CA2804168A1 Linear dna molecule delivery using pegylated quantum dots for stable transformation in plants |
| 01/12/2012 | CA2804164A1 Production of functionalized linear dna cassette and quantum dot/nanoparticle mediated delivery in plants |
| 01/12/2012 | CA2804019A1 Fatty alcohol forming acyl reductases (fars) and methods of use thereof |
| 01/12/2012 | CA2803719A1 Production cell line |
| 01/12/2012 | CA2803571A1 Method for producing tumor cells from normal mammary epithelial cells |
| 01/12/2012 | CA2801843A1 Biotechnological production of chondroitin |
| 01/12/2012 | CA2800461A1 Biological information processing method and device, recording medium and program |
| 01/11/2012 | EP2405272A1 Detectable nucleic acid tag |
| 01/11/2012 | EP2405268A1 Method for detecting substance in biological sample |
| 01/11/2012 | EP2405019A1 Methods, reagents, kits and apparatus for protein function analysis |
| 01/11/2012 | EP2405018A1 Method for determining fatty acid synthesis pathway of microorganism, and pcr primer set for use in the method |
| 01/11/2012 | EP2405015A2 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof |
| 01/11/2012 | EP2405014A1 Fermentive production of four carbon alcohols |
| 01/11/2012 | EP2405013A2 Compositions and methods for the suppression of target polynucleotides from the family Aphididae |
| 01/11/2012 | EP2405012A1 Delta-8 desaturase and its use in making polyunsaturated fatty acids |
| 01/11/2012 | EP2405011A2 Plants having enhanced yield-related traits and a method for making the same |
| 01/11/2012 | EP2405010A1 Plant egg cell transcriptional control sequences |
| 01/11/2012 | EP2405009A2 Transgenic plants containing soluble cell wall polysaccharides |
| 01/11/2012 | EP2405008A1 Bacterial surface display of thioether-bridge-containing peptides |
| 01/11/2012 | EP2405007A1 Production of a lipid acyltransferase from transformed bacillus cells |
| 01/11/2012 | EP2405006A2 Microorganism which produces l-amino acid and method for producing l-amino acid using the same |
| 01/11/2012 | EP2405005A2 Microorganism which produces l-amino acid and method for producing l-amino acid using the same |
| 01/11/2012 | EP2405004A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/11/2012 | EP2405003A1 Recombinant vaccines against caligid copepods (sea lice) and antigen sequences thereof |
| 01/11/2012 | EP2405002A1 Compositions and methods for oligonucleotide formulations |
| 01/11/2012 | EP2405001A1 Nucleic acid complex and nucleic acid-delivering composition |
| 01/11/2012 | EP2405000A1 Synthesis of chemical libraries |
| 01/11/2012 | EP2404999A1 Thermotolerant transglutaminase originating in actinomyces |
| 01/11/2012 | EP2404998A2 Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient |
| 01/11/2012 | EP2404997A1 Method for enhancing function of t cell |
| 01/11/2012 | EP2404996A1 Transcription regulatory factors for mannanases or cellulases, and genes for the transcription regulatory factors |
| 01/11/2012 | EP2404995A1 Enzyme associated with equol synthesis |
| 01/11/2012 | EP2404994A1 Enzyme associated with equol synthesis |
| 01/11/2012 | EP2404935A1 Immunoglobulin binding HOSM |
| 01/11/2012 | EP2404934A1 Protease resistant insulin analogues |
| 01/11/2012 | EP2404927A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 01/11/2012 | EP2404616A2 Binding proteins specific for insulin-like growth factors and uses thereof |
| 01/11/2012 | EP2404610A1 Prophylactic or therapeutic agent for rheumatoid arthritis or rheumatoid arthritis-related diseases |
| 01/11/2012 | EP2404500A1 A transgenic animal as a model for identifying adult stem cells, and uses thereof |
| 01/11/2012 | EP2404499A2 Nucleic acid molecules encoding Lipid Metabolism Protein (LMP) and methods of use in plants |
| 01/11/2012 | EP2403963A1 A biomarker and treatment for cancer |
| 01/11/2012 | EP2403956A2 Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics |
| 01/11/2012 | EP2403952A1 Device and method for treating cells |
| 01/11/2012 | EP2403951A2 Tumor-selective e1a and e1b mutants |
| 01/11/2012 | EP2403950A1 Plants of genus diplotaxis having male cytoplasmic sterility |
| 01/11/2012 | EP2403949A1 Stable, fertile, high polyhydroxyalkanoate producing plants and methods of producing them |
| 01/11/2012 | EP2403948A1 Methods and compositions for controlling plant pests |
| 01/11/2012 | EP2403947A2 Method for the oral/mucosal vaccination by means of recombinant yeasts |
| 01/11/2012 | EP2403946A2 Treatment of sirtuin 1 (sirt1) related diseases by inhibition of natural antisense transcript to sirt 1 |
| 01/11/2012 | EP2403945A2 Rna molecules and therapeutic uses thereof |
| 01/11/2012 | EP2403944A2 Methods for cloning and manipulating genomes |
| 01/11/2012 | EP2403943A1 Vangl1 peptides and vaccines including the same |
| 01/11/2012 | EP2403942A1 Control of key ethylene hormone signaling pathway proteins in plants |
| 01/11/2012 | EP2403940A2 Nucleic acids for cloning and expressing multiprotein complexes |
| 01/11/2012 | EP2403939A1 A diguanylate cyclase, method of producing the same and its use in the manufacture of cyclic-di-gmp and analogues thereof |
| 01/11/2012 | EP2403934A1 Improved production of 2-keto-l-gulonic acid |
| 01/11/2012 | EP2403867A2 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3 |
| 01/11/2012 | EP2403865A2 Compositions, methods and kits for preparing plasminogen; and plasmin prepared therefrom |
| 01/11/2012 | EP2403864A2 Polypeptide structural motifs associated with cell signaling activity |
| 01/11/2012 | EP2403530A2 Engineered proteins with high affinity for dota chelates |
| 01/11/2012 | EP2403525A2 Attenuated salmonella enterica serovar paratyphi a and uses thereof |
| 01/11/2012 | EP2403329A2 Hydroperoxide lyase genes and tolerance to abiotic stress in plants |
| 01/11/2012 | EP2160468B1 Screening tool for antiviral agents |
| 01/11/2012 | EP2131662B1 Process of producing tomato paste |
| 01/11/2012 | EP2102347B9 Corynebacterium glutamicum variety producing l-arginine and method for fabricating the same |
| 01/11/2012 | EP2054515B1 Use of a phage displaying a peptide from an adhesion protein for treating a disease associated with intracellular formation of protein fibrillar inclusions or aggregates |
| 01/11/2012 | EP2011868B1 Modified creatinine amide hydrolase having improved affinity for substrate, and reagent composition for determination of creatinine |
| 01/11/2012 | EP1986696B1 Method for production of a transformed cell |
| 01/11/2012 | EP1948215B1 MacroH2A non-histone domain as inhibitor of PARP-1 activity and uses thereof |
| 01/11/2012 | EP1789167B1 Method of stably producing microporous membrane and use thereof in method of separating and purifying nucleic acid |
| 01/11/2012 | EP1766001B1 Nocardiopsis proteases |
| 01/11/2012 | EP1725666B1 Plants with reduced activity of the starch phosphorylating enzyme phosphoglucan, water dikinase |
| 01/11/2012 | EP1712126B1 Method of constructing a transgenic bird. |
| 01/11/2012 | EP1682583B1 Protein complex using immunoglobulin fragment and method for the preparation thereof |
| 01/11/2012 | EP1649025B1 Methods of decoupling reaction scale and protein synthesis yield in batch mode |
| 01/11/2012 | EP1601784B1 Multiple controls for molecular genetic analyses |
| 01/11/2012 | EP1572074B1 Stabilized synthetic immunogen delivery system |
| 01/11/2012 | EP1565210B1 Clostridial neurotoxin for use in the treatment of nasal congestion |
| 01/11/2012 | EP1558648B1 Human monoclonal antibodies against cd20 |
| 01/11/2012 | EP1546343B1 High titer recombinant aav production |
| 01/11/2012 | EP1511845B1 Immunostimulatory oligonucleotides and uses thereof |
| 01/11/2012 | EP1483384B1 Method for overexpression of zwitterionic polysaccharides |
| 01/11/2012 | EP1468092B1 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 01/11/2012 | EP1402070B1 Methods for the diagnosis of cancer based on the obcam and ntm genes |
| 01/11/2012 | EP1395108B1 Sugar and lipid metabolism regulators in plants |
| 01/11/2012 | EP1334659B1 Pd-1-lacking mouse and use thereof |
| 01/11/2012 | EP1203337B1 Profile searching in nucleic acid sequences using the fast fourier transformation |
| 01/11/2012 | EP1180932B1 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 01/11/2012 | EP1019432B1 The ob receptor and methods of diagnosing and treating weight |
| 01/11/2012 | EP0975672B1 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 01/11/2012 | CN1948483B SiRNA for inhibiting human Rabj gene expression and its application |
| 01/11/2012 | CN1948482B Antisensedigonucleotides sequence for inhibiting human Rabj gene expression and its application |
| 01/11/2012 | CN1764842B Microchip, nucleic acid extracting kit, and nucleic acid extracting method |
| 01/11/2012 | CN1720330B Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS) and herbicide-tolerant plants containing it |
| 01/11/2012 | CN102317473A Shenzhen tcl new technology co. , ltd |